BiomEdit’s Designer Probiotics Target Animal Health Market

BiomEdit is advancing the animal health sector with its genetically engineered probiotics aimed at preventing necrotic enteritis in broiler chickens. The product, expected to receive regulatory approval by Q4 2026, represents a significant innovation in microbial solutions, potentially transforming disease management in livestock and offering new opportunities for agrifood investors and operators.

Original excerpt: BiomEdit’s first product—a pair of genetically engineered microbes designed to protect broiler chickens from necrotic enteritis—could secure the regulatory green light by Q4, 2026…

Source: AgFunderNews